
FDA Grants Breakthrough Status for Staph Infection Treatment
A new bacteria-fighting treatment just earned FDA breakthrough status for drug-resistant staph bloodstream infections. The phage therapy will move to Phase 3 trials, offering hope for patients who've run out of antibiotic options.
















